Literature DB >> 21561983

An integrated care pathway improves the management of paracetamol poisoning.

Janice M Pettie1, Margaret A Dow, Euan A Sandilands, H K Ruben Thanacoody, D Nicholas Bateman.   

Abstract

BACKGROUND: Paracetamol poisoning remains a major cause of morbidity and mortality. Clinical care of paracetamol poisoning depends on a range of patient variables and typically involves both medical and nursing care. An integrated care pathway (ICP) is a multidisciplinary management plan that incorporates guidelines and best practice to enhance care and documentation for a specific patient group. Paracetamol overdose is thus amenable to an ICP. AIM: To evaluate the introduction of an ICP on process of care of the paracetamol poisoned patient.
METHODS: A retrospective case note review of consecutive patients admitted to the Royal Infirmary of Edinburgh following a paracetamol overdose was conducted. Data were collected for a 3-month period before and after introduction of the ICP to the emergency department and toxicology inpatient unit.
RESULTS: The ICP was used in 77% of cases in the time period studied and was associated with improvements in initial documentation of patient assessment (pre-ICP vs post-ICP: 87/161 (54%) vs 101/113 (89%), p<0.0001) and appropriateness of blood sampling (146/161 (91%) vs 111/113 (98%), p=0.01), but no change in timely blood sampling (pre 124/161 (77%) vs post 93/113 (82%)). All aspects of intravenous acetylcysteine administration also significantly improved: administration of acetylcysteine if indicated (pre-ICP vs post-ICP: 57/71 (80%) vs 71/71 (100%), p<0.0001); acetylcysteine commenced in a timely fashion (33/71 (46%) vs 55/71 (77%), p=0.0002); and acetylcysteine correctly prescribed (44/58 (76%) vs 71/71 (100%), p<0.0001).
CONCLUSIONS: Implementation of an ICP for paracetamol poisoning significantly improved patient management and helped to standardise inter-professional decision making in this challenging patient group. This is likely to improve patient outcome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21561983     DOI: 10.1136/emj.2011.111922

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  7 in total

Review 1.  Poisoning and self-harm.

Authors:  D N Bateman
Journal:  Clin Med (Lond)       Date:  2012-06       Impact factor: 2.659

2.  Delays during the administration of acetylcysteine for the treatment of paracetamol overdose.

Authors:  George P Bailey; Javad Najafi; Muhammad E M O Elamin; W Stephen Waring; Simon H L Thomas; John R H Archer; David M Wood; Paul I Dargan
Journal:  Br J Clin Pharmacol       Date:  2016-08-10       Impact factor: 4.335

3.  Paracetamol toxicity: What would be the implications of a change in UK treatment guidelines?

Authors:  David J McQuade; Paul I Dargan; Jeff Keep; David M Wood
Journal:  Eur J Clin Pharmacol       Date:  2012-04-19       Impact factor: 2.953

4.  Use of the online poisons information database TOXBASE and admissions rates for poisoned patients from emergency departments in England and Wales during 2008 to 2015.

Authors:  Kate Pyper; Chris Robertson; Michael Eddleston; Euan Sandilands; D Nicholas Bateman
Journal:  J Am Coll Emerg Physicians Open       Date:  2020-06-13

5.  How to build and evaluate an integrated health care system for chronic patients: study design of a clustered randomised controlled trial in rural China.

Authors:  Wenxi Tang; Xiaowei Sun; Yan Zhang; Ting Ye; Liang Zhang
Journal:  Int J Integr Care       Date:  2015-03-16       Impact factor: 5.120

6.  N-Acetylcysteine for Preventing Acetaminophen-Induced Liver Injury: A Comprehensive Review.

Authors:  Anna Licata; Maria Giovanna Minissale; Simona Stankevičiūtė; Judith Sanabria-Cabrera; Maria Isabel Lucena; Raul J Andrade; Piero Luigi Almasio
Journal:  Front Pharmacol       Date:  2022-08-10       Impact factor: 5.988

Review 7.  The effects of integrated care: a systematic review of UK and international evidence.

Authors:  Susan Baxter; Maxine Johnson; Duncan Chambers; Anthea Sutton; Elizabeth Goyder; Andrew Booth
Journal:  BMC Health Serv Res       Date:  2018-05-10       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.